Volume 15, Issue 1, February 2012

Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD

• Abstract
• View article

Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial

• Abstract
• View article

The evidence-based pharmacological treatment of paediatric ADHD

• Abstract
• View article

Cognitive and emotional behavioural changes associated with methylphenidate treatment: a review of preclinical studies

• Abstract
• View article

Aquaporin-4 deficiency exacerbates brain oxidative damage and memory deficits induced by long-term ovarian hormone deprivation and D-galactose injection

• Abstract
• View article

Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia

• Abstract
• View article

Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease

• Abstract
• View article

Serotonin at the level of the amygdala and orbitofrontal cortex modulates distinct aspects of positive emotion in primates

• Abstract
• View article

A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia

• Abstract
• View article
• Supplementary data

A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia – Corrigendum

• Extract
• View article

Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression

• Abstract
• View article

The effect of rosiglitazone on LRP1 expression and amyloid β uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment

• Abstract
• View article
• Supplementary data

Reviewers for 2011

• Extract
• View article